Abstract:Objective To evaluate the effects of the synthetic osteogenic growth peptide (sOGP) on the healing of tibial fractures in rabbits. Methods Fifty two tibial fracture models were produced in the tibiae of New Zealand white rabbits and immobilized with a 2 mm diameter Kirschner wire as intramedullary nail and grouped by random. sOGP was administered to experimental animals by intravenous injection (0.5 μg·kg-1 ·d-1) from the first day after surgery until the day before sacrifice, while the control animals were injected with saline solution. 3-5 rabbits from each group were killed at 1, 2, 3, 4, 6 weeks after fracture. The serum was obtained to determine the level of ALP and BGP by biochemistry and RIA respectively. The bone mineral density at fracture healing site was detected by DXA, the anteroposterior and lateral radiographs were taken, the histological examination was done and quantitative analysis of the callus area and the relative amounts of bone, cartilage, and fibrous tissue in the callus of each section were calculated by computer program. The 6 weeks tibial sample were tested biomechanically by universal material test machine. Results The serum ALP, BGP level were higher in sOGP injected groups than those in the controls. All tibia osteotomies healed uneventfully on radiograph. The area of the external callus was larger in the experimental groups than that in controls at 3,4 weeks after fracture; the average area was 265.44 mm2 at 3 weeks, 233.10 mm2 at 4 weeks in the experimental groups compared with that of 209.95 mm2 at 3 weeks and 209.21 mm2 at 4 weeks in the controls. The average bone mineral density at fracture healing site was slightly greater in the experimental group at 3,4,6 weeks, and the difference of the bone mineral density at 4 weeks has statistical significance (P 0.05). Quantitative analysis of histological examination showed that the overall size of the external calluses was greater for the experimental groups than those of the controls at 2,3,4 weeks. The amount of external callus in the experimental group was greater than that in the control group at each period, and the difference at 2, 4 weeks had statistical significance (P 0.05). The biomechanical test results also showed the average peak load and peak deformation of the fracture healing site at 6th week were greater in the experimental group, but there was no statistical significance. Conclusion Systemically administering sOGP 6 weeks after fracture may play some significant role in the healing of tibia fracture under intramedullary fixation in New Zealand white rabbits.

Clinical efficacy analysis of Compound Ossotide Injection on promoting limb fracture healing

Clinical Effectiveness of Ossotide Injection Combined with Hyperbaric Oxygen in Patients with Tibial Fractures and Its Effects on Bone Marker Levels and Joint Function

Clinical analysis of the treatment of thoracolumbar fracture by calcium sulfate liquid artificial bone strengthening the fractured vertebral

An Observation of Efficacies of Ossotide Injection, and Cervus and Cucumis Polypeptide Injection on Fracture of Children

Study on the effect of early dynamic of interlocking intramedullary nail in promoting the healing and controlling the bad situation of patients with tibial fracture

Effects of Glucocorticoids on Fracture Healing in Rats

Experimental Study of High-Energy Fractures Delayed Operation in Promote Bone Healing.

Effect of Simvastatin on Osteoprotegerin Expression in Bone Callus of Ovariectimized Rats

Efficacy and safety of Osteoking on fracture healing: a systematic review and meta-analysis

Clinical study on effect of osteoking in preventing postoperational deep venous thrombosis in patients with intertrochanteric fracture

Clinical study on effect of osteoking (Chinese characters) in preventing postoperational deep venous thrombosis in patients with intertrochanteric fracture

Influence of Postoperative Anti-osteoporosis Therapy on Diabetes Patients with Fractures

The effect of synthetic osteogenic growth peptide on tibia fracture healing in rabbits

Intermittent low-dose administration of recombinant human parathyroid hormone (1-34) promotes the expression of Osterix during early stage of fracture healing

Effect of the combination treatment with human parathyroid hormone( 1-34) and zoledronic acid on fracture healing in osteoporotic rats

Osthole Promotes Bone Fracture Healing through Activation of BMP Signaling in Chondrocytes

Study on Zoledronic Acid Reducing Acute Bone Loss and Fracture Rates in Elderly Postoperative Patients with Intertrochanteric Fractures

The Experimental Study on Promoting the Ilizarov Distraction Osteogenesis by the Injection of Liquid Alg/nHAC Biocomposites

The Use of Osteogenon as an Adjunctive Treatment in Lower Leg Fractures

Clinical observation of biomimetic mineralized collagen artificial bone putty for bone reconstruction of calcaneus fracture.

Once-weekly subcutaneous injection of recombinant human parathyroid hormone (1-34) promotes the bone fracture healing in rats